Skip to main contentSkip to navigation
Sirius Investors

ABMC Stock: American Bio Medica Corporation Stock Price, Analysis & Insights

Get live ABMC stock price $0.00, comprehensive American Bio Medica Corporation stock analysis, charts, news, and expert forecast. Real-time ABMC stock data and investment insights.

0.00
0.00%Today
ABMCAmerican Bio Medica Corporation • Other OTC • Healthcare
Market Cap
4.81K
Volume
2.40K
52W High
0.00
52W Low
0.00

Loading chart data...

American Bio Medica Corporation (ABMC) Overview

American Bio Medica Corporation (ABMC) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, ABMC trades at $0.00 with a market capitalization of 4.81K . Over the past 52 weeks, ABMC has traded between $0.00 and $0.00 , with the current price positioned at approximately 0% of this range . The...

Key Takeaways

  • Operates in the Healthcare sector (Medical - Diagnostics & Research)
  • Market cap: 4.81K
  • Current price: $0.00
  • 52-week range: $0.00 - $0.00
  • P/E ratio: 0.01

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

American Bio Medica Corporation (ABMC) specializes in the development and distribution of lateral flow immunoassay tests, primarily designed for the rapid detection of drugs in both urine and oral fluid samples. Their extensive range of urine-based d...

Company Information

CEO
Jean Neff
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
16

Contact Information

Address
122 Smith Road
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Diagnostics & Research

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 0.0)

Lower volatility stock (Beta: -0.12) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for American Bio Medica Corporation shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for American Bio Medica Corporation
  • Investors should consider how American Bio Medica Corporation fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

4.81K

P/E Ratio (TTM)

0.01

Beta

-0.12

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.